Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (3)

Search Parameters:
Keywords = migration and proliferation dichotomy

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
14 pages, 1700 KiB  
Article
Cell Migration–Proliferation Dichotomy in Cancer: Biological Fact or Experimental Artefact?
by Abdulaziz Alfahed
Biology 2024, 13(10), 753; https://doi.org/10.3390/biology13100753 - 24 Sep 2024
Cited by 3 | Viewed by 2002
Abstract
The migration–proliferation dichotomy (MPD) has long been observed in cultured cancer cells. This phenomenon is not only relevant to tumour progression but may also have therapeutic significance in clinical cancer. However, MPD has rarely been investigated in primary cancer. This study aimed to [...] Read more.
The migration–proliferation dichotomy (MPD) has long been observed in cultured cancer cells. This phenomenon is not only relevant to tumour progression but may also have therapeutic significance in clinical cancer. However, MPD has rarely been investigated in primary cancer. This study aimed to either confirm or disprove the existence of MPD in primary cancer. Using primary gastric, colorectal and prostate cancer (GC, CRC and PCa) cohorts from the Cancer Genome Atlas and Memorial Sloan Kettering Cancer Center, this study interrogated the MPD phenomenon by utilising RNA–Seq-based proliferation (CIN70 signature) and migration (epithelial-mesenchymal transition) indices, as well as gene set enrichment analyses (GSEA). Alternative hypothetical migration–proliferation models—The simultaneous migration–proliferation (SMP) and phenotype–refractory (PR) models—were compared to the MPD model by probing the migration–proliferation relationships within cancer stages and between early- and late-stage diseases using chi-square and independent T tests, z-score statistics and GSEA. The results revealed an inverse relationship between migration and proliferation signatures overall in the GC, CRC and PCa cohorts, as well as in early- and late-stage diseases. Additionally, a shift in proliferation- to migration dominance was observed from early- to late-stage diseases in the GC and CRC cohorts but not in the PCa cohorts, which showed enhanced proliferation dominance in metastatic tumours compared to primary cancers. The above features exhibited by the cancer cohorts are in keeping with the MPD model of the migration–proliferation relationship at the cellular level and exclude the SMP and PR migration–proliferation models. Full article
Show Figures

Figure 1

25 pages, 1678 KiB  
Review
A Narrative Review on CD44’s Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence
by Akihiro Inoue, Takanori Ohnishi, Masahiro Nishikawa, Yoshihiro Ohtsuka, Kosuke Kusakabe, Hajime Yano, Junya Tanaka and Takeharu Kunieda
Cancers 2023, 15(19), 4898; https://doi.org/10.3390/cancers15194898 - 9 Oct 2023
Cited by 19 | Viewed by 3335
Abstract
High invasiveness is a characteristic of glioblastoma (GBM), making radical resection almost impossible, and thus, resulting in a tumor with inevitable recurrence. GBM recurrence may be caused by glioma stem-like cells (GSCs) that survive many kinds of therapy. GSCs with high expression levels [...] Read more.
High invasiveness is a characteristic of glioblastoma (GBM), making radical resection almost impossible, and thus, resulting in a tumor with inevitable recurrence. GBM recurrence may be caused by glioma stem-like cells (GSCs) that survive many kinds of therapy. GSCs with high expression levels of CD44 are highly invasive and resistant to radio-chemotherapy. CD44 is a multifunctional molecule that promotes the invasion and proliferation of tumor cells via various signaling pathways. Among these, paired pathways reciprocally activate invasion and proliferation under different hypoxic conditions. Severe hypoxia (0.5–2.5% O2) upregulates hypoxia-inducible factor (HIF)-1α, which then activates target genes, including CD44, TGF-β, and cMET, all of which are related to tumor migration and invasion. In contrast, moderate hypoxia (2.5–5% O2) upregulates HIF-2α, which activates target genes, such as vascular endothelial growth factor (VEGF)/VEGFR2, cMYC, and cyclin D1. All these genes are related to tumor proliferation. Oxygen environments around GBM can change before and after tumor resection. Before resection, the oxygen concentration at the tumor periphery is severely hypoxic. In the reparative stage after resection, the resection cavity shows moderate hypoxia. These observations suggest that upregulated CD44 under severe hypoxia may promote the migration and invasion of tumor cells. Conversely, when tumor resection leads to moderate hypoxia, upregulated HIF-2α activates HIF-2α target genes. The phenotypic transition regulated by CD44, leading to a dichotomy between invasion and proliferation according to hypoxic conditions, may play a crucial role in GBM recurrence. Full article
(This article belongs to the Special Issue Advanced Research in Oncology in 2023)
Show Figures

Figure 1

18 pages, 352 KiB  
Article
Migration and Proliferation Dichotomy: A Persistent Random Walk of Cancer Cells
by Hamed Al Shamsi
Fractal Fract. 2023, 7(4), 318; https://doi.org/10.3390/fractalfract7040318 - 7 Apr 2023
Cited by 3 | Viewed by 2143
Abstract
A non-Markovian model of tumor cell invasion with finite velocity is proposed to describe the proliferation and migration dichotomy of cancer cells. The model considers transitions with age-dependent switching rates between three states: moving tumor cells in the positive direction, moving tumor cells [...] Read more.
A non-Markovian model of tumor cell invasion with finite velocity is proposed to describe the proliferation and migration dichotomy of cancer cells. The model considers transitions with age-dependent switching rates between three states: moving tumor cells in the positive direction, moving tumor cells in the negative direction, and resting tumor cells. The first two states correspond to a migratory phenotype, while the third state represents a proliferative phenotype. Proliferation is modeled using a logistic growth equation. The transport of tumor cells is described by a persistent random walk with general residence time distributions. The nonlinear master equations describing the average densities of cancer cells for each of the three states are derived. The present work also includes the analysis of models involving power law distributed random time, highlighting the dominance of the Mittag–Leffler rest state, resulting in subdiffusive behavior. Full article
(This article belongs to the Section Life Science, Biophysics)
Back to TopTop